サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1622680

単一光子放射型コンピュータ断層撮影（SPECT）の世界市場規模：製品別、用途別、エンドユーザー別、地域別、範囲および予測

Global Single-Photon Emission Computed Tomography (SPECT) Market Size By Product (Standalone SPECT, Hybrid SPECT), By Application (Cardiology, Oncology), By ENd-User (Hospitals, Diagnostic Imaging Centers), By Geographic Scope And Forecast

出版日
ページ情報
英文 202 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
単一光子放射型コンピュータ断層撮影（SPECT）の世界市場規模：製品別、用途別、エンドユーザー別、地域別、範囲および予測
出版日: 2024年07月16日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

単一光子放射型コンピュータ断層撮影（SPECT）の市場規模と予測

単一光子放射型コンピュータ断層撮影（SPECT）市場規模は、2024年に18億8,000万米ドルと評価され、2024年から2031年にかけてCAGR 6.70%で成長し、2031年には31億5,000万米ドルに達すると予測されます。単一光子放射型コンピュータ断層撮影（SPECT）市場は、SPECT技術の開発および世界の心臓疾患やがん疾患の発生率の上昇により拡大しています。さらに、近代的な診断施設への投資の増加や、診断に関する人々の知識の高まりがSPECT産業の成長を支えています。世界の単一光子放射型コンピュータ断層撮影（SPECT）市場レポートは、市場の全体的な評価を提供します。主要セグメント、動向、市場促進要因、抑制要因、競合情勢、市場で重要な役割を果たしている要因などを包括的に分析しています。

世界の単一光子放射型コンピュータ断層撮影（SPECT）市場の定義

単一光子放射型コンピュータ断層撮影（SPECT）と呼ばれる画像検査は、様々な臓器や組織への血液の流れを明らかにします。心血管疾患、がん、神経疾患、脳卒中、発作、ストレス骨折、感染症、脊髄腫瘍などを特定するために利用されます。核医学画像検査では、放射性トレーサーとコンピュータ断層撮影（CT）が診断に使用されます。放射性標識トレーサーは、CTスキャナーが検出できるガンマ線を放出することで、医療専門家が組織や臓器への血液の流れを調べることができます。コンピューターはガンマ線の放出からデータを収集し、CT断面図に表示します。脳やその他の臓器は、この断面図を用いて三次元的に表示されます。

SPECTでは、テクネチウム-99m、タリウム-201、オジン-123、フッ素-18、キセノン-133などの放射性同位元素が使用されます。脳や脊椎の動脈や静脈を通る血流は、SPECTスキャンで検出することができます。SPECTは患部への血流低下を特定するために利用されるため、MRIやCTスキャンよりも脳損傷に対して正確な所見が得られる可能性があることが研究で実証されています。心臓の血流は心臓SPECTスキャンで調べられます。血流が不十分な心臓の部位は暗く見え、血流が正常な部位は明るく見えます。さらに、ストレス骨折やシンスプリントなど、発見されていない骨折の診断にも使用されます。

世界の単一光子放射型コンピュータ断層撮影（SPECT）市場概要

市場は、悪性腫瘍、心血管疾患、その他の重篤な疾患に罹患する患者の増加により拡大しています。市場は主に急成長するヘルスケア産業が牽引しています。高齢化が進み、座りっぱなしのライフスタイルがもたらす病気が蔓延しているため、市場の拡大が見込まれています。また、SPECT装置の診断能力の開発は、デュアルモダリティや臓器別システムの利用が増加していることも大きな要因となっています。市場拡大を促進するもう一つの要素は冠動脈疾患の増加です。現在、ハイブリッドSPECTイメージング・システムのニーズが高まっています。市場拡大を促す他の2つの要因は、放射性医薬品の生産に関する研究の拡大と、この検査タイプが他のイメージング技術と比較して有する複数の利点に関する一般知識の増加です。新しい放射性トレーサーの開発とシステム設計の継続的な技術改善が市場拡大をさらに後押ししています。ガリウム-67は腫瘍診断と病期分類のゴールドスタンダードです。ハイブリッドイメージングでGa-67 SPECT/CTを用いれば、リンパ腫病変を正確に同定できます。

Ga-67は、金属-トランスフェリン複合体として炎症組織に特異的に集中せず、その後トランスフェリン受容体にさらに結合する能力があるため、炎症のイメージングによく使用される薬剤です。Lantheus Medical Imaging社やMallinckrodt Nuclear社など多くの市場参入企業がクエン酸ガリウムGA-67を提供しています。その結果、市場は予測期間中に急速に拡大し、ガリウム-67の利点だけでなく、様々ながんや骨の状態の頻度の上昇の結果として、ビジネスの可能性を提示すると予測されています。分子同位元素は画像診断機器に必要であるが、予測期間を通じて供給不足と入手性の悪さが世界のSPECT市場の拡大を抑制すると予測されます。一例として、心臓病学において多くのSPECT手技に利用されるテクネチウムとモリブデンの2つの化学元素については、過去数年間に何度も供給不足が発生しています。

分子状同位元素の供給に影響を与えたもう一つの要因は、同位元素を供給する原子炉が安全上の懸念から一部の地域で無期限に停止したことです。製品のリコールもSPECTの世界市場を苦しめている要因の一つです。心血管疾患、がん、脳機能障害などの病変、疾患、臓器機能障害に対するSPECT装置の適用は、再病期分類、診断、病期分類、経過観察に悪影響を及ぼします。SPECT装置の世界市場は、製品リコールやSPECT装置による悪影響のため、収益の増加に問題を抱えています。

目次

第1章 単一光子放射型コンピュータ断層撮影（Spect）の世界市場：イントロダクション

  • 市場概要
  • 調査範囲
  • 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

  • データマイニング
  • バリデーション
  • 一次インタビュー
  • データソース一覧

第4章 単一光子放射型コンピュータ断層撮影（Spect）の世界市場展望

  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • ポーターのファイブフォースモデル
  • バリューチェーン分析

第5章 単一光子放射型コンピュータ断層撮影（Spect）の世界市場：製品別

  • 概要
  • スタンドアロンSPECT
  • ハイブリッドSPECT

第6章 単光子CTの世界市場：用途別

  • 概要
  • 循環器
  • オンコロジー
  • 一般画像診断
  • 神経学
  • その他

第7章 単一光子放射型コンピュータ断層撮影（Spect）の世界市場：エンドユーザー別

  • 概要
  • 病院
  • 画像診断センター
  • 外来手術センター

第8章 単一光子放射型コンピュータ断層撮影（Spect）の世界市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
    • その他のラテンアメリカ
  • 中東・アフリカ
    • アラブ首長国連邦
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第9章 単一光子放射型コンピュータ断層撮影（Spect）の世界市場：競合情勢

  • 概要
  • 各社の市場ランキング
  • 主な開発戦略

第10章 企業プロファイル

  • GE Healthcare
  • Philips Healthcare
  • Siemens Healthineers
  • Bruker
  • Toshiba Medical（Canon）
  • Digirad Corporation
  • Esaote
  • Invicro
  • LambdaSpect
  • Mediso Medical Imaging Systems

第11章 主な発展

  • 製品上市／開発
  • 合併と買収
  • 事業拡大
  • パートナーシップと提携

第12章 付録

  • 関連調査
目次
Product Code: 20926

Single-Photon Emission Computed Tomography (SPECT) Market Size And Forecast

Single-Photon Emission Computed Tomography (SPECT) Market size was valued at USD 1.88 Billion in 2024 and is projected to reach USD 3.15 Billion by 2031, growing at a CAGR of 6.70% from 2024 to 2031. The Single-Photon Emission Computed Tomography (SPECT) Market is expanding as a result of developments in SPECT technology as well as the rising incidence of cardiac and cancer disorders worldwide. Furthermore, increased investment in modern diagnostic facilities and rising knowledge among people regarding diagnosis are supporting the growth of the SPECT Industry. The Global Single-Photon Emission Computed Tomography (SPECT) Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Single-Photon Emission Computed Tomography (SPECT) Market Definition

An imaging examination called a single photon emission computed tomography (SPECT) reveals how blood flows to various organs and tissues. It is utilized to identify cardiovascular problems, cancer, and neurological conditions as well as strokes, seizures, stress fractures, infections, and spinal tumours. A radioactive tracer and computed tomography (CT) are used in a nuclear imaging scan to provide a diagnosis. The radiolabeled tracer allows medical professionals to examine how blood flows to tissues and organs by emitting gamma rays that the CT scanner can detect. Computers gather data from the gamma-ray emissions, which are then shown on the CT cross-sections. The brain and other organs are shown in three dimensions using these cross-sections.

In the SPECT, radioisotopes including technetium-99m, thallium-201, odine-123, fluorine-18, and xenon-133 are used. Blood flow via arteries and veins in the brain and spine can be detected with a SPECT scan. Studies have demonstrated that because it is utilized to identify decreased blood flow to affected regions, it may provide more accurate findings for brain injury than MRI or CT scanning. The blood flow through the heart is examined using cardiac SPECT scans; regions of the heart with inadequate blood flow will look dark, while parts with normal blood flow will appear bright. Furthermore, it is used to diagnose undetected bone fractures, such as stress fractures and shin splints.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Single-Photon Emission Computed Tomography (SPECT) Market Overview

The market is growing because of the increase in individuals suffering from malignancies, cardiovascular diseases, and other critical ailments. The market is primarily driven by the quickly growing healthcare industry. The market is expected to expand because of ageing populations and the prevalence of ailments brought on by a sedentary lifestyle. The development of SPECT equipment's diagnostic capabilities has also been considerably aided by the rising usage of dual-modality and organ-specific systems throughout time. Another element driving market expansion is the rise in coronary artery diseases. The need for hybrid SPECT imaging systems is currently increasing. Two other factors that encourage expansion are expanding research into the production of radiopharmaceuticals and increasing public knowledge of the multiple benefits that the testing type has over other imaging techniques. The development of new radiotracers and ongoing technological improvements in system design further boost market expansion. Gallium-67 is the gold standard for tumour diagnosis and staging. Using Ga-67 SPECT/CT in hybrid imaging, lymphoma lesions may be accurately identified.

Ga-67 is a commonly used agent for the imaging of inflammation because of its ability to concentrate not specifically in inflamed tissues as a metal-transferrin complex, followed by further binding to transferrin receptors. A number of market participants, including Lantheus Medical Imaging and Mallinckrodt Nuclear, provides gallium citrate GA-67. Consequently, it is projected that the market would expand rapidly during the forecast period and present business possibilities as a result of the rising frequency of different cancers and bone conditions as well as the benefits of gallium-67. Molecular isotopes are required for diagnostic imaging equipment, however, throughout the anticipated period, a shortage of supply and insufficient availability of these isotopes is predicted to restrain the expansion of the global SPECT market. As an example, there have been multiple supply shortages for the two chemical elements technetium and molybdenum during the past few years, which are often utilized in a significant number of SPECT procedures in cardiology.

An additional factor that has had an impact on the supply of molecular isotopes is the fact that the reactors that provided the isotopes were indefinitely shut down in some regions owing to safety-related concerns. Recalls of products are another factor that is hurting the global market for SPECT. The application of SPECT equipment for lesions, illnesses, and organ dysfunctions, such as cardiovascular disease, cancer, and brain dysfunction, has adverse effects on restaging, diagnosis, staging, and follow-up. The global market for SPECT devices is having problems increasing its revenue because of product recalls and the negative impacts of SPECT devices.

Global Single-Photon Emission Computed Tomography (SPECT) Market Segmentation Analysis

The Global Single-Photon Emission Computed Tomography (SPECT) Market is segmented on the basis of Product, Application, End-User, And Geography.

Single-Photon Emission Computed Tomography (SPECT) Market, By Product

  • Standalone SPECT
  • Hybrid SPECT

Based on Product, the market is bifurcated into Standalone SPECT and Hybrid SPECT. The Standalone SPECT technology segment accounted for the largest market share in 2022 and is projected to grow at a significant CAGR during the forecast period. The segment's expansion is driven by cancer and heart divisions' increasing use of Standalone SPECT. Gamma ray-based nuclear medicine imaging systems are a type of standalone SPECT. The device can produce high-quality full-body tomographic pictures in real time and detects the gamma-ray emissions from an injected radioisotope to provide images for diagnosis and illness management.

Single-Photon Emission Computed Tomography (SPECT) Market, By Application

  • Cardiology
  • Oncology
  • General Imaging
  • Neurology
  • Other

Based on Application, the market is bifurcated into Cardiology, Oncology, General Imaging, Neurology, and Other. The segment cardiology accounted for the largest market share in 2022 and is projected to grow at the highest CAGR during the forecast period. Cardiologists use SPECT to see the different parts of the heart's blood flow. By administering a radioactive tracer that has been tagged with gamma cameras, doctors can examine where and how well blood flows into and around the heart. These let doctors determine whether conditions like atherosclerosis, coronary artery disease, hypertension, valvular illnesses like mitral valve prolapse, congenital bicuspid valves caused by an infection in early childhood, etc. have negatively impacted a patient's heart. The segment is expanding as a result of the globalization of cardiovascular diseases as well as increased public knowledge of heart disease diagnostics.

Single-Photon Emission Computed Tomography (SPECT) Market, By End-User

  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers

Based on End-User, the market is segmented into hospitals, diagnostic imaging centers, and ambulatory surgical centers. Hospitals segment accounted for the largest market share in 2022 and is projected to grow at the highest CAGR during the forecast period. The market is expected to expand as a result of ageing populations and the prevalence of ailments brought on by a sedentary lifestyle. The development of SPECT equipment's diagnostic capabilities has also been considerably aided by the rising usage of dual-modality and organ-specific systems throughout time.

Single-Photon Emission Computed Tomography (SPECT) Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

Based on regional analysis, the Global Single-Photon Emission Computed Tomography (SPECT) Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America accounted for the largest market share and is projected to grow at a significant CAGR during the forecast period. The region's big ageing population, high prevalence of cancer cases, and high number of cardiac patients are all driving the growth of the SPECT market there.

Key Players

  • The "Global Single-Photon Emission Computed Tomography (SPECT) Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
  • Siemens Healthineers, Bruker, Toshiba Medical (Canon), Digirad Corporation, Esaote, Invicro, GE Healthcare, Philips Healthcare, LambdaSpect, Mediso Medical Imaging Systems, MR Solutions, TriFoil Imaging, among others.
  • This section provides a company overview, ranking analysis, company regional and industry footprint, and ACE Matrix.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Key Developments

  • In March 2022, Two radiopharmaceuticals in development by GE Healthcare are one for Positron Emission Tomography (PET) and the other is for Single-Photon Release Calculated Tomography imaging. A PET radiopharmaceutical imaging intermediary that intends to help in the assessment of adult patients with purported Parkinsonian disorders, provide research, and enhance patient maintenance was recently announced by the business as having its first patient treated in Phase III clinical study.
  • In June 2021, Noria Therapeutics Inc. and PSMA Therapeutics Inc. have entered into a contract with Bayer to be acquired. Through this deal, Bayer will acquire the sole rights to a small molecule targeted at prostate-specific membrane antigen (PSMA) and a differentiated alpha radionuclide investigational drug based on actinium-225.
  • In March 2021, IBA (Ion Beam Applications SA and EURONEXT) and NorthStar Medical Radioisotopes LLC declared a partnership to expand technetium-99m (Tc-99m) availability on a worldwide scale. By working together, NorthStar and IBA may develop non-uranium-based Mo-99 for their proprietary Tc-99m Generation Systems (TCM Generation Systems), which are available to businesses outside of the US.
  • In November 2020, Prismatic Sensors AB, a Swedish start-up specialising on photon including detectors, was acquired by GE Healthcare, indicating the company's sustained strength in photon counting CT technology. The scientific performance for cancer, cardiology, neurology, and many other clinical CT claims may be greatly improved with this understanding.
  • Ace Matrix Analysis
  • The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as
  • Active, Cutting Edge, Emerging, and Innovators.
  • Market Attractiveness
  • The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Single-Photon Emission Computed Tomography (SPECT) Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.
  • Porter's Five Forces
  • The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the Global Single-Photon Emission Computed Tomography (SPECT) Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

TABLE OF CONTENTS

1 INTRODUCTION OF THE GLOBAL SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porter's Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY PRODUCT

  • 5.1 Overview
  • 5.2 Standalone SPECT
  • 5.3 Hybrid SPECT

6 GLOBAL SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Cardiology
  • 6.3 Oncology
  • 6.4 General Imaging
  • 6.5 Neurology
  • 6.6 Other

7 GLOBAL SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY END USER

  • 7.1 Overview
  • 7.2 Hospitals
  • 7.3 Diagnostic Imaging Centers
  • 7.4 Ambulatory Surgical Centers

8 GLOBAL SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 The U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 The U.K.
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Argentina
    • 8.5.3 Rest of LATAM
  • 8.6 Middle East and Africa
    • 8.6.1 UAE
    • 8.6.2 Saudi Arabia
    • 8.6.3 South Africa
    • 8.6.4 Rest of the Middle East and Africa

9 GLOBAL SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 GE Healthcare
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Philips Healthcare
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Siemens Healthineers
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Bruker
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Toshiba Medical (Canon)
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Digirad Corporation
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Development
  • 10.7 Esaote
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Invicro
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Development
  • 10.9 LambdaSpect
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Development
  • 10.10 Mediso Medical Imaging Systems
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Development

11 KEY DEVELOPMENTS

  • 11.1 Product Launches/Developments
  • 11.2 Mergers and Acquisitions
  • 11.3 Business Expansions
  • 11.4 Partnerships and Collaborations

12 Appendix

  • 12.1 Related Research